secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001104659-23-075515
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics shareholders approve stock plan amendment increasing shares by 1M, extend plan to 2033
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2015 Stock Incentive Plan, increasing authorized shares by 1,000,000 and extending plan to April 20, 2033.
- All 12 director nominees elected, with votes for ranging from 33.8M to 39.6M; broker non-votes of 1.4M on each.
- Advisory vote on executive compensation approved: 38.7M for, 1.2M against, 220.6K abstain.
- Frequency of future say-on-pay votes set at 1 year (39.1M votes).
- Ratification of Ernst & Young as independent auditor approved: 40.7M for, 748.9K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923075515/0001104659-23-075515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923075515/tm2319668d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-075515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer